BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37182124)

  • 1. Predictive value of intratumoral-metabolic heterogeneity derived from
    Zhang L; Liu Y; Ding Y; Deng Y; Chen H; Hu F; Fan J; Lan X; Cao W
    Front Oncol; 2023; 13():1065744. PubMed ID: 37182124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive Value of Metabolic Parameters Derived From
    Liu H; Ye Z; Yang T; Xie H; Duan T; Li M; Wu M; Song B
    Front Immunol; 2021; 12():724464. PubMed ID: 34512653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic activity via
    Song J; Li Z; Yang L; Wei M; Yang Z; Wang X
    BMC Cancer; 2022 Jul; 22(1):808. PubMed ID: 35869469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between
    Liu X; Wang SC; Ni M; Xie Q; Zhang YF; Lv WF; Geng GY
    Abdom Radiol (NY); 2022 Apr; 47(4):1255-1264. PubMed ID: 35138462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and validation of a nomogram with intratumoral heterogeneity derived from
    Gu B; Zhang J; Ma G; Song S; Shi L; Zhang Y; Yang Z
    BMC Cancer; 2020 Jan; 20(1):37. PubMed ID: 31941465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does high [
    Cha J; Kim H; Shin HJ; Lee M; Jun S; Kang WJ; Cho A
    Eur Radiol; 2023 Nov; 33(11):7450-7460. PubMed ID: 37338560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity index evaluated by slope of linear regression on
    Kim YI; Kim YJ; Paeng JC; Cheon GJ; Lee DS; Chung JK; Kang KW
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1995-2003. PubMed ID: 28634684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value of Intratumor Metabolic Heterogeneity Parameters on
    Liu X; Xiang K; Geng GY; Wang SC; Ni M; Zhang YF; Pan HF; Lv WF
    Contrast Media Mol Imaging; 2022; 2022():2586245. PubMed ID: 35173559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of intratumor metabolic and heterogeneity parameters on [
    Ni M; Wang S; Liu X; Shi Q; Zhu X; Zhang Y; Xie Q; Lv W
    Jpn J Radiol; 2023 Feb; 41(2):209-218. PubMed ID: 36219311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of regional lymph node status using (18)F-FDG PET/CT parameters in oesophageal cancer patients: comparison of SUV, volumetric parameters and intratumoral heterogeneity.
    Kim SJ; Pak K; Chang S
    Br J Radiol; 2016; 89(1058):20150673. PubMed ID: 26607643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation study on 18F-FDG PET/CT metabolic characteristics of primary lesion with clinical stage in lung cancer.
    Hu WD; Wang HC; Wang YB; Cui LL; Chen XH
    Q J Nucl Med Mol Imaging; 2021 Jun; 65(2):172-177. PubMed ID: 30916535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlations of
    Wang JL; Shi AQ; Fan CC; Wang YZ; Guo GR; Liu JY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Aug; 44(4):628-635. PubMed ID: 36065696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumoral heterogeneity of (18)F-FDG uptake predicts survival in patients with pancreatic ductal adenocarcinoma.
    Hyun SH; Kim HS; Choi SH; Choi DW; Lee JK; Lee KH; Park JO; Lee KH; Kim BT; Choi JY
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1461-8. PubMed ID: 26872788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of single-source dual-energy CT imaging for discriminating microsatellite instability from microsatellite stability human colorectal cancer.
    Wu J; Lv Y; Wang N; Zhao Y; Zhang P; Liu Y; Chen A; Li J; Li X; Guo Y; Wu T; Liu A
    Eur Radiol; 2019 Jul; 29(7):3782-3790. PubMed ID: 30903331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic implication of intratumoral metabolic heterogeneity in invasive ductal carcinoma of the breast.
    Son SH; Kim DH; Hong CM; Kim CY; Jeong SY; Lee SW; Lee J; Ahn BC
    BMC Cancer; 2014 Aug; 14():585. PubMed ID: 25112709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of Microsatellite Instability in Colorectal Cancer Using a Machine Learning Model Based on PET/CT Radiomics.
    Kim S; Lee JH; Park EJ; Lee HS; Baik SH; Jeon TJ; Lee KY; Ryu YH; Kang J
    Yonsei Med J; 2023 May; 64(5):320-326. PubMed ID: 37114635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction value of
    Liu X; Zhang YF; Shi Q; Yang Y; Yao BH; Wang SC; Geng GY
    Front Oncol; 2022; 12():945939. PubMed ID: 36158649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratumoral metabolic heterogeneity by
    Chao F; Wang R; Han X; Huang W; Wang R; Yu Y; Lin X; Yuan P; Yang M; Gao J
    Thorac Cancer; 2024 May; ():. PubMed ID: 38757212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective analysis of the
    Yang Y; Pan YQ; Wang M; Gu S; Bao W
    Radiat Oncol; 2023 Dec; 18(1):196. PubMed ID: 38049843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value on SUV-derived parameters assessed on
    Liao X; Liu M; Li S; Huang W; Guo C; Liu J; Xiong Y; Zhang J; Fan Y; Wang R
    BMC Med Imaging; 2023 Apr; 23(1):49. PubMed ID: 37020286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.